IL319490B1 - תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור - Google Patents

תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור

Info

Publication number
IL319490B1
IL319490B1 IL319490A IL31949025A IL319490B1 IL 319490 B1 IL319490 B1 IL 319490B1 IL 319490 A IL319490 A IL 319490A IL 31949025 A IL31949025 A IL 31949025A IL 319490 B1 IL319490 B1 IL 319490B1
Authority
IL
Israel
Prior art keywords
linked
cross
composition
micronized
combination
Prior art date
Application number
IL319490A
Other languages
English (en)
Other versions
IL319490B2 (he
IL319490A (he
Inventor
Zingboim Hava
Lubart Rachel
Lipovsky Anat
ZINGBOIM GANZ Emuna
Original Assignee
H Zingboim Cosmetics Products Ltd
Zingboim Hava
Lubart Rachel
Lipovsky Anat
ZINGBOIM GANZ Emuna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Zingboim Cosmetics Products Ltd, Zingboim Hava, Lubart Rachel, Lipovsky Anat, ZINGBOIM GANZ Emuna filed Critical H Zingboim Cosmetics Products Ltd
Priority to IL319490A priority Critical patent/IL319490B2/he
Publication of IL319490A publication Critical patent/IL319490A/en
Publication of IL319490B1 publication Critical patent/IL319490B1/he
Publication of IL319490B2 publication Critical patent/IL319490B2/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/07—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media from polymer solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
IL319490A 2025-03-09 2025-03-09 תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור IL319490B2 (he)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL319490A IL319490B2 (he) 2025-03-09 2025-03-09 תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL319490A IL319490B2 (he) 2025-03-09 2025-03-09 תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור

Publications (3)

Publication Number Publication Date
IL319490A IL319490A (he) 2025-04-01
IL319490B1 true IL319490B1 (he) 2026-03-01
IL319490B2 IL319490B2 (he) 2026-07-01

Family

ID=99398260

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319490A IL319490B2 (he) 2025-03-09 2025-03-09 תכשירים של חומצה הילאורונית מצולבת ממוזערת ושימושיה בהן לשיפור מראה העור

Country Status (1)

Country Link
IL (1) IL319490B2 (he)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166530A1 (en) * 2007-07-25 2011-07-07 S & V Technologies Ag Hyaluronic acid dispersion, production and use
US20120258155A1 (en) * 2007-12-19 2012-10-11 Novozymes Biopolymer A/S Crosslinked hyaluronic acid in emulsion
US20170290947A1 (en) * 2014-10-08 2017-10-12 Therakine Bio Delivery GmbH Micronized hydrophilic cross-linked biopolymer systems and method of making same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166530A1 (en) * 2007-07-25 2011-07-07 S & V Technologies Ag Hyaluronic acid dispersion, production and use
US20120258155A1 (en) * 2007-12-19 2012-10-11 Novozymes Biopolymer A/S Crosslinked hyaluronic acid in emulsion
US20170290947A1 (en) * 2014-10-08 2017-10-12 Therakine Bio Delivery GmbH Micronized hydrophilic cross-linked biopolymer systems and method of making same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SZILVIA BERK? ET AL, ADVANTAGES OF CROSS-LINKED VERSUS LINEAR HYALURONIC ACID FOR SEMISOLID SKIN DELIVERY SYSTEMS, 15 April 2013 (2013-04-15) *

Also Published As

Publication number Publication date
IL319490B2 (he) 2026-07-01
IL319490A (he) 2025-04-01

Similar Documents

Publication Publication Date Title
IL313161A (he) תכשירים ושיטות למתן יעיל לגוף
NZ600439A (en) Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
WO2010049438A3 (en) Improved methods of using phosphoantigens for the treatment of diseases
WO2007038252A3 (en) Methods and compositions for treating skin lines and wrinkles and improving skin quality
IL319320A (he) אלמנטים לביטול ייעוד ביטוי גן בגנגליון שורש גבי ו/או כבד
GB202412949D0 (en) Methods and compositions for including meiosis in cancer cells as treatment for cancer
AU2024366343A1 (en) Catechol-urethane compositions and methods for use in wet-bonding
HK40118663A (en) Compositions and methods for efficient in vivo delivery
CA3308898A1 (en) Catechol-urethane compositions and methods for use in wet-bonding
HK40129430A (en) Elements for de-targeting gene expression in dorsal root ganglion and/or liver
CA3300949A1 (en) Collagen peptide composition and use thereof in ameliorating neurological conditions and fibrosis
GB202415036D0 (en) Composition and methods and uses relating thereto
GB202402961D0 (en) Composition and uses thereof
GB202418962D0 (en) Composition and use thereof
GB202509785D0 (en) Compositions and methods and uses relating thereto
GB202509788D0 (en) Compositions and methods and uses relating thereto
GB202509789D0 (en) Compositions and methods and uses relating thereto
GB202508303D0 (en) Compositions and methods and uses relating thereto
GB202501871D0 (en) Compositions and methods and uses relating thereto
GB202408878D0 (en) Compositions and methods and uses relating thereto
GB202408877D0 (en) Compositions and methods and uses relating thereto
GB202408881D0 (en) Compositions and methods and uses relating thereto
GB202503093D0 (en) Compositions and uses thereof
GB202415081D0 (en) Composition and use
GB202414230D0 (en) Compositions and uses thereof